Schonfeld Strategic Advisors’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-3,120
| Closed | -$18.1K | – | 1960 |
|
2022
Q4 | $18.1K | Sell |
3,120
-2,880
| -48% | -$16.7K | ﹤0.01% | 2271 |
|
2022
Q3 | $57K | Hold |
6,000
| – | – | ﹤0.01% | 2564 |
|
2022
Q2 | $72K | Hold |
6,000
| – | – | ﹤0.01% | 2106 |
|
2022
Q1 | $79K | Buy |
+6,000
| New | +$79K | ﹤0.01% | 2211 |
|
2020
Q4 | – | Sell |
-14,230
| Closed | -$1.47M | – | 1492 |
|
2020
Q3 | $1.47M | Buy |
14,230
+8,630
| +154% | +$888K | 0.03% | 564 |
|
2020
Q2 | $1.17M | Buy |
5,600
+4,406
| +369% | +$920K | 0.03% | 531 |
|
2020
Q1 | $117K | Sell |
1,194
-8,715
| -88% | -$854K | 0.01% | 984 |
|
2019
Q4 | $1.14M | Sell |
9,909
-58,761
| -86% | -$6.77M | 0.03% | 480 |
|
2019
Q3 | $3.74M | Buy |
+68,670
| New | +$3.74M | 0.11% | 206 |
|
2016
Q2 | – | Sell |
-1,000
| Closed | -$52K | – | 419 |
|
2016
Q1 | $52K | Buy |
+1,000
| New | +$52K | 0.02% | 296 |
|